New investment helps to ensure patients can access high-quality and reproducible testing across labs worldwide NEW YORK, June 2, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced an investment of up to $2M to expand a quality control program for blood...
Hence then, the article about the alzheimer s drug discovery foundation s diagnostics accelerator dxa invests in expansion of quality control program for blood and csf biomarkers was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers )
Also on site :
- '90s One-Hit Wonder That Became a Worldwide Phenomenon Began a 14-Week Run at No. 1, 30 Years Ago Today
- 1973 Hit, Written by One of the 'Best Rock Bands' of All Time, Is Still a Generational Hit 53 Years Later
- If you purchased a 48-inch or taller Bestway above-ground pool with straps running to the outside of the vertical legs since 2008, you may be entitled to benefits from a class action Settlement.